Results 231 to 240 of about 5,563 (240)

Enhancing T cell cytotoxicity in multiple myeloma with bispecific αPD-L1 × αCD3 T cell engager-armed T cells and low-dose bortezomib therapy

Biomedicine and Pharmacotherapy
Nunghathai Sawasdee, Chutamas Thepmalee, Mutita Junking   +2 more
exaly  

Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B

Antiviral Research
Ulrike Protzer, Zhe Xie
exaly  

A Bite of B Cells: The Potential Role of Bispecific T Cell Engager Therapy (BiTE) in Autoimmune Diseases

International Journal of Rheumatic Diseases
Yung-Heng Lee
exaly  

Passive immunotherapy by T cell–engaging bispecific antibodies

2011
Patrick A. Baeuerle, Benno Rattel
openaire   +1 more source

Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine

Molecular Therapy
Saru Basnet, Anna Kanerva, Santeri Pakola   +2 more
exaly  

The Real‐World Safety and Efficacy of Bispecific T‐Cell Engager Therapy in Systemic AL Amyloidosis

American Journal of Hematology
Julian Kelley, André De Menezes Silva Corraes, Kimberly Green   +2 more
exaly  

Bispecific T-cell engager therapy for gastrointestinal cancers

Cancer Letters
Kyle A. Burton, Anastasia E. Metropulos, Suneel D. Kamath, Hidayatullah G. Munshi, Daniel R. Principe   +4 more
openaire   +1 more source

FDA approves first DLL3 × CD3 bispecific T-cell engager for lung cancer

Nature Reviews Drug Discovery
exaly  

Cranking Out Bispecific T-Cell Engagers, In Vivo

Cancer Discovery
openaire   +1 more source

Don't get BiTEn by bispecific T-cell engagers

First10EM blog
openaire   +1 more source